These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 17728023)

  • 21. South India immunoprophylaxis trial against leprosy: relevance of findings in the context of leprosy trends.
    Gupte MD
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S10-3. PubMed ID: 11757173
    [No Abstract]   [Full Text] [Related]  

  • 22. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
    De Britto RL; Ramanathan VD; Gupte MD
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The distribution and implications of BCG scars in northern Malawi.
    Fine PE; Ponnighaus JM; Maine N
    Bull World Health Organ; 1989; 67(1):35-42. PubMed ID: 2706726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
    Gupte MD; Vallishayee RS; De Britto LJ; Anantharaman DS
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case-control study of protection against tuberculosis by BCG revaccination in Recife, Brazil.
    Dantas OM; Ximenes RA; de Albuquerque Mde F; da Silva NL; Montarroyos UR; de Souza WV; Pereira TC; Campelo AR; Rodrigues LC
    Int J Tuberc Lung Dis; 2006 May; 10(5):536-41. PubMed ID: 16704036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
    Zodpey SP
    Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence rates of leprosy in Karonga District, northern Malawi: patterns by age, sex, BCG status and classification.
    Pönnighaus JM; Fine PE; Sterne JA; Bliss L; Wilson RJ; Malema SS; Kileta S
    Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):10-23. PubMed ID: 8189075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention.
    Schuring RP; Richardus JH; Pahan D; Oskam L
    Vaccine; 2009 Nov; 27(50):7125-8. PubMed ID: 19786134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam.
    Thuc NV; Abel L; Lap VD; Oberti J; Lagrange PH
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):532-8. PubMed ID: 7868950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study of three potential vaccines for leprosy in Bombay.
    Ganapati R; Revankar CR; Lockwood DN; Wilson RC; Price JE; Ashton P; Ashton LA; Holmes RM; Bennett C; Stanford JL
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):33-7. PubMed ID: 2659699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vaccine trials against leprosy].
    Gupta MD
    Acta Leprol; 1999; 11(2):45-7. PubMed ID: 19785197
    [No Abstract]   [Full Text] [Related]  

  • 33. BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in Burma.
    Bechelli LM; Garbajosa PG; Gyi MM; Uemura K; Sundaresan T; Martínez Domínguez V; Matejka M; Tamondong C; Quagliato R; Engler V; Altmann M
    Bull World Health Organ; 1973; 48(3):323-34. PubMed ID: 4270384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization against leprosy: progress and prospects.
    Noordeen SK; Sansarricq H
    Bull World Health Organ; 1984; 62(1):1-6. PubMed ID: 6370487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of BCG vaccination among leprosy contacts: a cohort study.
    Düppre NC; Camacho LA; da Cunha SS; Struchiner CJ; Sales AM; Nery JA; Sarno EN
    Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):631-8. PubMed ID: 18514242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The future incidence of leprosy: a scenario analysis.
    Meima A; Smith WC; van Oortmarssen GJ; Richardus JH; Habbema JD
    Bull World Health Organ; 2004 May; 82(5):373-80. PubMed ID: 15298228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BCG vaccination of children against leprosy: nine-year findings of the controlled WHO trial in Burma.
    Bechelli LM; Lwin K; Gallego Garbajosa P; Mg-Mg-Gyi ; Uemura K; Sundaresan T; Tamondong C; Matejka M; Sansarricq H; Walter J
    Bull World Health Organ; 1974; 51(1):93-9. PubMed ID: 4281729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of BCG on the risk of leprosy in an endemic area: a case control study.
    Muliyil J; Nelson KE; Diamond EL
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):229-36. PubMed ID: 2071979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Eradication of leprosy and public health. Vaccination and multidrug therapy].
    Janaszek W
    Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis.
    Katoch K; Singh P; Adhikari T; Benara SK; Singh HB; Chauhan DS; Sharma VD; Lavania M; Sachan AS; Katoch VM
    Vaccine; 2008 Feb; 26(9):1228-34. PubMed ID: 18243430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.